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Abstract
Thyroidectomy augments the natriuretic response to volume expansion; how-
ever, the mechanism remains unknown. This study assessed the role of 20-hy-
droxyeicosatetraenoic acid (20-HETE) in the natriuretic response to an acute
volume expansion in hypothyroid rats. Urine flow (1.9-fold), sodium excre-
tion (2.4-fold), fractional sodium excretion (3.8-fold), and distal delivery of
sodium (4.1-fold) increased to a greater extent in thyroidectomized rats (TX)
than in sham-operated controls (SHAM) following i.v. infusion of isotonic
saline (5% body weight) over 60 min. This was associated with inhibition of
both proximal and distal tubular reabsorption of sodium. Administration of
two mechanistic and chemical dissimilar inhibitors of the synthesis of 20-
HETE, 1-aminobenzotriazole (ABT), and N-hydroxy-N’-(-4-butyl-2-methyl-
phenyl)formamidine (HET0016) decreased the natriuretic response in TX rats.
Glomerular filtration rate was lower in TX than in SHAM rats and was not
altered by the CYP4A inhibitors. The expression, intrarenal distribution, and
the formation of 20-HETE and expoxygenase metabolites of arachidonic acid
were similar in the cortex and medulla of SHAM and TX rats. These results
suggest that CYP4A-derived metabolites of arachidonic acid play an important
role in the enhanced natriuretic response to volume expansion in hypothyroid
rats even though TX did not alter the expression or activity of these enzymes.
Introduction
The excretion of sodium and water under basal condi-
tions (Bradley et al. 1974) and the natriuretic response to
volume expansion (Holmes and DiScala 1970; Singleton
et al. 1999) is markedly elevated in thyroidectomized rats.
However, the mechanism for the enhanced natriuretic
response remains to be determined.
Cytochrome P450 (CYP) metabolites of arachidonic
acid (AA) in the kidney play an important role in the
renal tubular handling of salt and water (Webb et al.
1996; Capdevila et al. 2007; Fernandez et al. 2012). Ara-
chidonic acid is metabolized in the kidney of rats by CYP
enzymes of the 2C and 2J pathways to epoxyeicosatrienoic
acids (EETs) and by CYP enzymes of the 4A family to 20-
hydroxyeicosatetraenoic acid (20-HETE). EETs inhibit
sodium transport in the proximal tubule and collecting
duct (Pavlov et al. 2011) while 20-HETE inhibits Na+/H+
exchange in the proximal tubule, Na+,K+-2Cl- transport
in the thick ascending limb of Henle’s loop, and Na+,
K+-ATPase activity in both nephron segments (Webb
et al. 1996; Nowicki et al. 1997; Yu et al. 2007).
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Previous studies have demonstrated that acute volume
expansion increases the renal release of dopamine (DA)
and that DA contributes to the natriuretic response by
inhibiting Na+,K+-ATPase activity in both the proximal
tubule and thick ascending loop of Henle (Aperia 2000).
Moreover, inhibitors of the synthesis of 20-HETE have
been reported to blunt the natriuretic response to DA
infusion (Fernandez et al. 2012), high-salt diet (Hoagland
et al. 2003), or acute elevations in blood pressure (Dos
Santos et al. 2004; Williams et al. 2010).
In addition, other studies have indicated that the
expression of CYP4A enzymes is regulated by the peroxi-
some proliferator-activated alpha receptor (PPARa)
(Johnson et al. 2002; Fernandez et al. 2012). Cooperative
heterodimerization of PPARa to the retinoid X receptor
(RXR) is obligatory for PPARa-dependent gene transcrip-
tion. In turn, RXR serves a similar role as a partner for
the binding of the receptors for thyroid hormone (triio-
dothyronine, T3), retinoic acid, and vitamin D. Thus, the
activity of other nuclear receptor signaling pathways that
utilize RXR may modulate PPARa activity (Johnson et al.
1996). Indeed previous studies have indicated that hyper-
thyroid state in rats reduces the ability of the peroxisome
proliferating agent dehydroepiandrosterone (DHEA) to
increase the renal expression of CYP4A1 and CYP4A3
mRNA by 60–80%, and to completely inhibit the induc-
tion of CYP4A2. This suggests that thyroid status of the
animal may affect the expression of CYP4A enzymes
(Vargas et al. 2006; Schwarz et al. 2012).
Thus, the purpose of this study was to test the hypoth-
esis that CYP4A metabolites of arachidonic acid contrib-
ute to the enhanced natriuretic response to an acute
sodium load seen in hypothyroid rats.
Methods
General
Experiments were performed on 9- to 10-week-old male
Sprague Dawley rats that were purchased from the Ani-
mal Breeding Facility from the School of Biochemistry,
University of Buenos Aires. The rats were housed in an
Animal Care Facility at the Ricardo Gutierrez Children0s
Hospital and had free access to food and water through-
out the study. All protocols were performed according to
the guidelines recommended by the National Institutes of
Health and were reviewed by the Institutional Animal
Welfare Committee in Buenos Aires.
Six experimental groups were studied. Group 1 served as
the control and the experiments were performed on euthy-
roid rats. In Group 2, the experiments were performed on
hypothyroid rats (TX) that were subjected to thyroidec-
tomy at 5 weeks of age and supplemented with 0.9% Ca2Cl
in drinking water. Group 3 were sham-operated control
rats (SHAM) that received 0.9% Ca2Cl in drinking water.
Group 4 were TX rats that received hormone replacement
with triiodothyronine (TX + T3) 5 lg/100 g for seven con-
secutive days prior to the experiment. Group 5 consisted of
TX rats treated with the nonselective CYP4A inhibitor 1-
aminobenzotriazole (TX + ABT) 50 mg/kg, i.p., 18 h
before the experiment. This dose has been shown to inhibit
the formation of 20-HETE by >80% while reducing forma-
tion of EETs and DiHetes by about 50% (Hoagland et al.
2003; Dos Santos et al. 2004). Group 6 were TX rats treated
with a highly selective inhibitor of the synthesis of
20-HETE, N-hydroxy-N’-(-4-butyl-2methylphenyl) form-
amidine (TX + HET0016) 10 mg/kg/day, i.p. for three
consecutive days prior to the experiment. This dose has
been reported to completely inhibit the formation of 20-
HETE and has no significant effect on epoxygenase activity
(Hoagland et al. 2003; Williams et al. 2007). ABT was dis-
solved in isotonic saline, whereas HET0016 was dissolved
in 3% mannitol + 11% captisol (sulfobutyl ether beta
cyclodextrin). Neither of the vehicles had an effect on any
of the studied parameters (data not shown).
Additional experiments were performed to confirm the
results obtained in TX rats using a second hypothyroid
model in rats treated with 6-n-propyl-2-thiouracil in
water (PTU). Group 7 served as control, and the rats in
Group 8 were treated with PTU (0.05 % P/V in drinking
water for 3 weeks (PTU) (Mourouzis et al. 2009). Group
9 consisted of PTU rats treated with HET0016 10 mg/kg/
day, i.p. for three consecutive days prior to the experi-
ment (PTU + HET0016).
The thyroid state of the animals was confirmed before
clearance studies by measuring serum T3 levels.
Clearance studies
The night before the acute clearance study, rats from
Groups 1, 2, and 3 were placed in metabolic cages to
measure baseline urine flow, sodium, and water excretion.
Then, the rats were anesthetized with thiopental (70 mg/
kg, i.p.) and surgical prepared for a renal clearance exper-
iment. The trachea was cannulated to facilitate breathing.
Catheters were placed in the carotid artery and femoral
vein to measure mean arterial pressure and for i.v. infu-
sions. The rats received an i.v. infusion of 0.9% NaCl
solution containing FITC-labeled inulin (4 mg/mL) and
LiCl (5 mmol/L) at a rate of 3 mL/h. After surgery and a
45-min stabilization period, urine and blood samples
(0.4 mL) were collected during two control periods of 15
min each. The animals then received an i.v. infusion of
5% of the rat’s body weight of 0.9% NaCl solution over a
60-min period. Urine flow and sodium excretion were
measured during 6 sequential 15-min clearance periods.
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Determination of the effect of
thyroidectomy on the renal expression of
CYP4A proteins
At the end of the clearance experiment the left kidney
was collected, separated into cortex and medulla, frozen
in liquid nitrogen, and stored at 80°C until it was pro-
cessed for measurement of the expression of CYP4A
enzymes. The other kidney was taken for immunohisto-
chemistry as described below. Samples of the renal cortex
and medulla were homogenized in a 10 mmol/L potas-
sium buffer (pH 7.7) containing (in mmol/L) 250
sucrose, 1 EDTA, and 0.1 phenylmethylsulfonylfluoride
(PMSF). The homogenate was centrifuged at 3000 g for
5 min and the supernatant was centrifuged at 11,000 g
for 15 min. The protein concentration in the supernatant
was measured using the Bradford method. Aliquots
(10 lg) were separated on a 10% SDS-PAGE gel and
transferred to PVDF membranes. Blots were probed with
rabbit polyclonal antibody to CYP4A (1:1500, Abcam,
Cambridge, U.K.). The membranes were stripped, washed,
and reblotted with mouse anti-b-tubulin primary anti-
body (1:3000; SigmaAldrich Co, Saint Louis, MO). The
blots were developed using ECL Plus Western Blotting
detection system (GE Healthcare UK Limited, Little
Chalfont, Buckinghamshire, U.K.). Detection and the rela-
tive intensity of the bands in the 50kDa were analyzed by
HP Precision Scan software (Hewlett-Packard, Palo Alto,
CA). The results are expressed as the relative intensity of
the CYP4A/b-tubulin bands.
Expression of CYP4A mRNA
The relative expression of CYP4A1, CYP4A2 and CYP4A3
mRNA, and b-actin mRNA (internal standard for each
sample) was determined in the cortex and medulla from
SHAM and TX rats using PCR. Total RNA was extracted
from renal cortex and medulla with Trizol. One lg of
total RNA was reversed transcribed using SuperScript II
and 1 lL of the cDNA was used for PCR using primers
published elsewhere (Ito et al. 1998). Optimal amplifica-
tion conditions were obtained for each PCR. The structure
of the primers used was as follows: P-450 4A1, +50 GTA
TCC AAG TCA CAC TCT CCA 30 and 50 CAG GAC
ACT GGA CAC TTT ATT G 30; P-450 4A2, +50 AGA TCC
AAA GCC TTA TCA ATC 30 and 50 CAG CCT TGG
TGT AGG ACC T 30; P-450 4A3, +50 CAA AGG CTT
CTG GAA TTT ATC 30 and 50 CAG CCT TGG TGT
AGG ACC T 30; P-450 4A8, +50 GGG CAT GAG TGG
CTC GG 30 and 50 GCA ATG ACC TGA GCT TTA TTC
30; b-actin, +50 TAA AGA CCT CTA TGC CAA CA 30 and
50 GAG CCA CCG ATC CAC A 30. For CYP4A1 and
CYP4A3, the cycling conditions were 94°C for 1 min,
60°C for 2 min, and 72°C for 2 min for 27 cycles. The
CYP4A2 reactions were cycled using a step-down protocol
for 94°C for 1 min, 70°C for 2 min, and 72°C for 2 min,
for nine cycles followed by 94°C for 1 min, 60°C for
2 min, and 72°C for 2 min, for 27 cycles. The samples
were separated on 2% agarose gels and stained with Ethi-
dium Bromide.
Immunohistochemistry
The right kidney was fixed by the retrograde perfusion
through the abdominal aorta with 200 mL of 4% parafor-
maldehyde containing 0.2% picric acid in 0.1 mol/L
phosphate buffer at 4°C. The kidneys were collected and
immersed in 4% paraformaldehyde for 24 h. The kidneys
were embedded in paraffin, and 5-lm-thick sections were
prepared. The antigens were retrieved by microwave-oven
treatment in sodium citrate buffer 0.01 mol/L, pH 6 for
3 min. The endogenous peroxidase activity was subse-
quently blocked with 3% H2O2 and the nonimmunologic
binding with phosphate-buffered saline containing 1%
bovine serum albumin. The slides were incubated with a
rabbit polyclonal antibody to CYP4A (1:500, Abcam) for
1 h at 4°C then extensively washed with TBS. The anti-
body complex was detected using the Sensitive Link-Label
IHC detection system and 3,30-diaminobenzidine (DAB)
as chromogen (BioGenex, San Ramon, CA).
CYP metabolism of Arachidonic Acid
One mg of renal cortical or medullary homogenate was
incubated with a saturating concentration of arachidonic
acid (40 lmol/L) for 1 h in the presence of 1 mmol/L
NADPH. The incubations were stopped by acidification to
pH 3.5 with formic acid, homogenized, and the homoge-
nate was extracted twice with 3 mL of ethyl acetate after
the addition of 2 ng of an internal standard, d6-20-hydrox-
yeicosatetraenoic acid. The organic phase was collected and
dried under nitrogen. The samples were reconstituted with
50% methanol and water, and the metabolites were ana-
lyzed using a Dionex (Sunnyvale, CA) HPLC system and
an ABsciex 4000 Q trap tandem mass spectrometer with
electrospray ionization (ABsciex, Foster City, CA) as
described previously (Fan et al. 2013).
The metabolites were first separated using a reverse-
phase column (Beta basic C18, 150 9 2.1 mm, 3 lm;
Thermo Hypersil-Keystone, Bellefonte, PA) and the
following mobile phase conditions at a flow rate of
300 lL/min. The column was equilibrated with 66.7% of
a mobile phase A containing water/acetonitrile/methanol/
acetic acid 90/8.5/1.4/0.1 (v/v/v/v), and 33.3% mobile
phase B, acetonitrile/methanol 85/15 for 5 min following
injection of the sample. The percentage of mobile phase B
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 6 | e12040
Page 3
C. Colombero et al. CYP4A and Sodium Excretion in Hypothyroid Rats
was ramped to 53.5% over a 10-min period and then held
there for 5 min followed by a linear increase to 94.4%
mobile phase B over a 7-min period and then held there
for another 5 min. Column temperature was maintained
at 35°C.
The products were ionized using the negative ion mode
and using multiple reaction monitoring (MRM) with the
following instrument settings: electrospray voltage 4500
volts, curtain gas 30, gas 1–50, temperature 600, gas 2–50,
and unit resolution. The following transitions were
monitored for each metabolite of AA; m/z 337-207
(14,15-DIHETE), m/z 337-167 (11,12-DIHETE), m/z 337-
127 (8,9-DIHETE), m/z 319-231 (19-HETE), m/z 319-245
(20-HETE), m/z 319-261 (18-HETE), m/z337-145
(5,6-DIHETE), m/z 319-233 (16-HETE), m/z 319-175
(15-HETE), m/z 319-149 (11-HETE), m/z 319-179 (12-
HETE), m/z 319-155 (8-HETE), m/z 319-203 (5-HETE),
m/z 319-175(14,15-EET), m/z 319-167 (11,12-EET), m/z
319-127 (8,9-EET), m/z 319-191 (5,6-EET), and m/z 325-
281/307 (d6 20-HETE) for the internal standard.
The ratios of ion abundance in the peaks of interest
versus those seen in the internal standard were deter-
mined and compared with standard curves generated over
a range from 0.1 to 2.0 ng for 20-HETE and from 1.0 to
10 ng for the other metabolites. Values are expressed as
picomoles of product formed per minute per milligram
of protein. Epoxygenase activity was calculated as the sum
of the products 5,6-EET, 8,9-EET, 11,12-EET, 14,15-EET
and their stable metabolites 5,6- DIHETE, 8,9- DIHETE,
11,12- DIHETE, 14,15- DIHETE, respectively.
Analysis of urine and plasma samples
The concentration of FITC inulin in plasma and urine
samples was measured using a Synergy HT microplate
reader (BioTek Instruments, Inc. Winooski, VT) with
excitation and emission wavelengths of 480 and 530,
respectively. Plasma T3 levels were measured using an
electrochemiluminescence immunoassay (Roche Diagnos-
tics, Cobas e411, Mannheim, Germany). Catecholamines
(Dopamine and Noradrenaline) were extracted from urine
using alumina, separated by reverse-phase high-pressure
liquid chromatography using a 4.6 9 150 mm, 5 lm C18
column (Agilent Life Sciences and Chemical Analysis,
Santa Clara, CA), and quantified amperometrically using
a triple-electrode system (ESA, Bedford, MA) (Eisenhofer
et al. 1986). Sodium concentration in plasma and urine
was measured by flame photometry, and lithium levels
were determined by Atomic Emission Spectrophotometry
using a Varian 240 FS atomic absorption spectrometer
(Agilent Technologies Inc., CA).
Urinary sodium excretion was calculated as (Urinary
[Na+] 9 Urine output (V)). Glomerular filtration rate
(GFR) was calculated from the clearance of FITC Inulin.
The filtered load of sodium was calculated as (Plasma
[Na+] 9 GFR), and fractional sodium excretion (FE Na+)
as (CNa+/CIN 9 100). Fractional delivery of sodium
from the proximal tubule (FE Na+ prox) was calculated
as (CLi+/CIN), and fractional delivery from the distal
nephron (FE Na+ dist) was calculated as (CNa+/CLi+)
(Christensen et al. 1986).
Statistics
Data are presented as mean values  SEM. The signifi-
cance in differences in mean values was performed using
a two-way repeated measures ANOVA followed by a Bon-
ferroni post hoc test. P value <0.05 was considered statis-
tically significant.
Results
General
Table 1 presents the characterization of the control, sham-
operated (SHAM), and thyroidectomized (TX) rats
(Groups 1, 2, and 3). Thyroidectomy reduced serum levels
of T3, and kidney and body weight. Noradrenaline excre-
tion, an indicator of sympathetic activity, was significantly
greater in TX than SHAM rats. Food and water intake was
not significantly different in the TX and SHAM rats. Simi-
larly, 24-h urine volume, sodium excretion, urinary osmo-
larity, and serum sodium concentrations were not
significantly different in the TX versus the SHAM rats.
Comparison of the response to volume
expansion
Figure 1 compares the response to volume expansion in
SHAM, TX, TX + ABT, and TX + HET0016 rats (Groups
2, 3, 5, and 6). Baseline urine flow was similar in all the
groups. After volume expansion, urine flow increased to a
greater extent in TX than in the SHAM controls
(35.2  4.5 vs. 18.7  2.5 lL/min 100 g; P < 0.05).
Treatment of TX rats with ABT completely abolished the
increase in urine flow in TX rats (7.1  1.4 lL/
min 100 g; P < 0.05 vs. TX rats). Similarly, HET0016
markedly reduced the increase in urine flow in the TX-
treated animals (19.7  1.4 lL/min 100 g; P < 0.05 vs.
TX rats) (Fig. 1A).
The effects of TX and the CYP inhibitors on the natri-
uretic response to volume expansion followed a similar
pattern. Baseline sodium excretion was similar in SHAM
and TX rats. Sodium excretion increased to a greater
extent in TX animals than in the SHAM controls
(9.6  0.5 vs. 4.0  0.4 lEq/min 100 g; P < 0.05). The
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natriuretic response to volume expansion in the TX ani-
mals was completely blocked by ABT (2.0  0.6 lEq/
min 100 g; P < 0.05 vs. TX rats) and was reduced by
42% in TX rats treated with HET0016 (5.6  0.4 lEq/
min 100 g; P < 0.05 vs. TX rats) (Fig. 1B).
There were no significant differences in GFR under
basal conditions between the various treatment groups.
GFR increased to a greater extent in SHAM than in TX
animals after volume expansion (3.2  0.3 vs. TX
1.2  0.2 mL/min 100 g; P < 0.05). Inhibition of CYP
activity with either ABT or HET0016 had no significant
effect on GFR before or after volume expansion in TX
rats (Fig. 1C). The filtered load of sodium was lower in
TX than in SHAM rats during volume expansion
(126  20 vs. 576  175 lEq/min; P < 0.01) and it was
not modified by treatment of TX rats with inhibitors of
CYP activity.
Baseline fractional excretion of sodium was similar in
TX and SHAM rats. After volume expansion it increased
to a far greater extent in TX animals than in SHAM con-
trol rats (6.2  0.9 vs. 1.6  0.3%; P < 0.05). ABT com-
pletely blocked the increase in the fractional excretion of
sodium after volume expansion in the TX rats
(1.1  0.3%; P < 0.05 vs. TX rats). HET0016 attenuated
the increase in fractional sodium excretion by about 50%
in these animals (3.2  0.3%; P < 0.05 vs. TX rats)
(Fig. 1D).
The fractional excretion of lithium was used to estimate
the inhibition of sodium transport in the proximal and
distal nephron after volume expansion. Baseline fractional
excretion of lithium, an index of proximal tubular reab-
sorption, was similar in all the groups. It increased in all
the groups after volume expansion; however, it was signif-
icantly lower in TX rats treated with ABT than in the TX
group (TX + ABT 39  8 vs. 54  9% in TX; P < 0.05)
(Fig. 1E). The fractional delivery of sodium from the dis-
tal nephron increased to a far greater extent in TX rats
after volume expansion than in the SHAM control ani-
mals (TX 12.8  1.2 vs. 3.1  0.9% in SHAM; P < 0.05).
The greater inhibition of the sodium transport in the dis-
tal nephron was normalized in TX rats pretreated with
HET0016 or ABT (6.8  1.4 and 5.1  0.6%, respec-
tively; P < 0.05 vs. TX rats) (Fig. 1F).
Basal blood pressure was similar in SHAM and TX rats
(142  5 vs. 138  3 mm Hg) and was not significantly
altered during the experiment. Similarly, blood pressure
was similar in ABT and HET0016-treated rats versus the
levels seen in TX rats.
Dopamine excretion rate was not statistically different
among SHAM, TX rats, and TX rats treated with ABT
during the control period. Dopamine excretion increased
after saline infusion in all groups. Treatment with ABT
did not modify DA excretion in response to volume
expansion in TX rats (Fig. 2). Similarly, there was no
significant difference in noradrenaline excretion between
TX rats and TX rats treated with ABT (data not
shown).
The effect of thyroidectomy to elevate the sodium
excretion was prevented by T3 replacement in Group 4.
As presented in Table 2, urine flow, GFR and sodium
excretion were similar before and after volume expansion
in CONTROL, SHAM, and TX + T3 rats (Groups 1, 3,
and 4).
The effects of the CYP4A inhibitors to normalize the
renal handling of sodium in a thyroid deficient state were
confirmed by analyzing sodium excretion in control rats
and rats treated with propylthiouracil (PTU) (Groups 7
and 8, respectively). Treatment with PTU decreased free
serum T3 levels from 121  6 to 72  2 ng/dL
(P < 0.01). Urine excretion during volume expansion was
Table 1. Characteristics of study groups.
Control (n = 5) SHAM (n = 5) TX (n = 5)
SHAM
versus TX
Control
versus SHAM
Free T3, ng/dL 121.2  6.0 129.2  2.6 56.1  4.9 P < 0.001 N.S.
Body weight, g 271  17 226  13 158  11 P < 0.01 N.S.
Daily body weight gain, % 4.85  0.12 4.24  0.32 1.52  0.17 P < 0.001 N.S.
Kidney weight, g 2.30  0.28 1.88  0.13 1.28  0.09 P < 0.05 N.S.
Food intake, g/24 h 14.2  1.6 13.7  1.6 11.7  1.3 N.S. N.S.
Water intake, mL/24 h 23.9  5.3 31.2  5.2 23.8  6.1 N.S. N.S.
Diuresis, mL/24 h 100 g 5.13  0.80 7.89  1.71 7.63  2.05 N.S. N.S.
Natriuresis, mEq/24 h 100 g 0.67  0.06 0.70  0.07 0.59  0.17 N.S. N.S.
Urine Osmolarity, mOsm/L 1982  103 1523  146 1518  213 N.S. N.S.
Plasma Na+, mEq/L 139.0  1.5 139.2  2.0 138.2  3.0 N.S. N.S.
NA excretion, ng/24 h 100 g 428  127 411  17 1387  287 P < 0.05 N.S.
Values are means  SE. TX, thyroidectomized rats; T3 triiodothyronine; NA, noradrenaline.
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higher in PTU-treated than in control rats (26.5  2.6 vs.
16.1  3.4 lL/min 100 g; P < 0.05). Similarly, sodium
excretion was significantly greater in PTU-treated rats in
comparison to the control group (6.8  1.1 vs.
3.5  0.6 lEq/min 100 g; P < 0.05). Treatment of the
PTU-hypothyroid rats with HET0016 (Group 9) restored
A B
C D
E F
Figure 1. Comparison of the effects of 1-aminobenzotriazole (ABT, 50 mg/kg, i.p.) and N-hydroxy-N’-(-4-butyl-2methylphenyl) formamidine
(HET0016, 10 mg/kg/day, i.p. 3 days) on the natriuretic response to i.v. infusion of isotonic saline (5% body weight, 60 min) in
thyroidectomized (TX) rats. Numbers in parentheses indicate the number of animals studied per group. Values are means  SEM. *indicates
P < 0.05 versus TX rats; #P < 0.05 versus the value prior to the volume expansion (30 min); §P < 0.05 TX + ABT versus TX + HET0016.
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both diuresis and natriuresis to values similar to controls
(diuresis 15.6  0.7 lL/min 100 g; sodium excretion
4.0  0.6 lEq/min 100 g; P < 0.05 vs. PTU for both)
(Fig. 3).
CYP4A expression and activity
The expression of the CYP4A protein in the renal cortex
and medulla isolated from SHAM and TX rats (Groups 2
and 3) is presented in Figure 4. CYP4A expression was
higher in cortex than in medulla, but it was not different
between SHAM and TX rats. Similarly, no differences
were found in the expression of CYP4A mRNA levels in
cortex or medulla isolated from TX versus SHAM rats
(Fig. 5).
CYP4A protein was expressed to a greater extent in the
proximal tubule than in the thick ascending loop of Hen-
le, but there was no obvious difference in the intensity or
distribution of CYP4A staining in the sections obtained
from SHAM and TX rats (Fig. 6).
We also examined the production of 20-HETE and
epoxygenase metabolites (EETs and DiHETEs) in the
renal cortex and outer medulla of SHAM and TX rats
incubated with arachidonic acid. The results presented in
Table 3 indicate that the production of 20-HETE was
higher in cortex than in medulla, but there was no
difference in the rate of production of 20-HETE
or Epoxygenase metabolites of AA in SHAM and TX
rats.
Figure 2. Effects of blockade of the renal CYP4A with
1-aminobenzotriazole (ABT, 50 mg/kg, i.p.) on dopamine excretion
in thyroidectomized (TX) rats during a control period (30 min) and
after volume expansion with isotonic saline. Values are
means  SEM. *indicates P < 0.05 versus the corresponding value
in TX rats; #P < 0.05 versus the value prior to the volume expansion
(30 min).
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Discussion
The results of this investigation suggest that CYP4A
metabolites of arachidonic acid play an important role in
the enhanced natriuretic response to volume expansion in
hypothyroid rats. This conclusion is based on the
observation that administration of two chemically and
mechanistically different inhibitors of the renal formation
of 20-HETE reduced the diuretic and natriuretic response
to an acute volume expansion in TX rats. The present
finding that ABT, which blocks the formation of both
EETs and 20-HETE, reduced the natriuretic response
more than that seen using the specific 20-HETE inhibitor,
HET0016, suggests that EETs may also contribute to the
enhanced natriuretic response to volume expansion in TX
rats.
Advanced hypothyroidism is associated with significant
abnormalities of renal function, sodium wasting and hypo-
natremia, an impaired ability to concentrate urine, and a
reduction in GFR associated with increased sympathetic
activity (Vargas et al. 1994; Iglesias and Dıez 2009). In this
study, using a moderate model of hypothyroidism in which
free T3 levels were reduced only by 50%, body and kidney
weight was reduced and urinary noradrenaline excretion
A B
Figure 3. Effect of N-hydroxy-N’-(-4-butyl-2methylphenyl) formamidine (HET0016, 10 mg/kg/day, i.p. 3 days) on the natriuretic response to an
i.v. infusion of isotonic saline (5% body weight, 60 min) in rats rendered hypothyroid by administration of 0.05 % P/V 6n-propyl-2-thiouracil in
water for 3 weeks (PTU). Numbers in parentheses indicate the number of animals studied per group. Values are means  SEM. *indicates
P < 0.05 versus the value prior to the volume expansion (30 min); #P < 0.05 versus the corresponding value in control rats.
A B
Figure 4. Expression of CYP4A and b-Tubulin protein in homogenates of renal cortex and medulla prepared from SHAM or thyroidectomized
(TX) rats. The densitometric analysis of the immunoreactivity of CYP4A, expressed as the ratio CYP4A/b-Tubulin, of 3–4 animals/group is also
shown. Values are means  SEM.
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was elevated as expected. However, in line with previous
findings in hypothyroid rats (Taylor and Fregly 1964; Cad-
napaphornchai et al. 2003) and patients (Baajafer et al.
1999; Asami and Uchiyama 2004; Schwarz et al. 2012), the
rats still were able to remain in sodium balance and base-
line urine flow and sodium excretion was not significantly
different in the SHAM-operated rats and TX rats.
Early studies performed on rats rendered hypothyroid
by thyroidectomy or chemical means showed that
hypothyroid rats exhibit an increased urine output and
fractional excretion of sodium after saline loading
(Holmes and DiScala 1970; Michael et al. 1972). The
present findings are consistent with these previous results.
Urine flow and sodium excretion increased to a far
greater extent in TX rats than in SHAM controls after
acute volume expansion in our study. Similar results were
obtained in a second PTU-induced model of hypothy-
roidism. Moreover, the enhanced natriuretic response to
volume expansion in TX animals was reversed by T3
replacement. These findings exclude the possibility that
augmented response in TX rats was secondary to electro-
lyte disturbances or due to damage to the parathyroid
glands during surgery.
It is well known that hypothyroidism is associated with
a reduction in GFR that may be secondary to suppression
of the Renin-Angiotensin Aldosterone System (RAAS)
(Vargas et al. 2006; Iglesias and Dıez 2009). As expected,
the increase in GFR triggered by volume expansion was
less in TX than in SHAM rats. Further analysis of our
results suggests that the increase in sodium excretion
despite reduced GFR following volume expansion in TX
rats was largely due to a greater inhibition of tubular
reabsorption. Inhibition of tubular transport in TX rats
has been previously documented and has been attributed
to the decreased expression of sodium transporters in
hypothyroid rats (Schmitt et al. 2003; Mariani and Berns
2012; Moreno et al. 2012). The results of our lithium
clearance study indicated that the enhanced natriuretic
response after volume expansion was due to more marked
inhibition of sodium transport in the distal nephron after
volume expansion in the TX animals.
The fact that the increase in diuresis and tubular
sodium excretion following saline infusion in TX rats was
markedly attenuated by the inhibition of CYP4A activity
strongly suggested that elevated levels of 20-HETE con-
tribute to the greater inhibition of tubular sodium reab-
sorption in hypothyroid rats. Based on previous reports
that the expression of CYP4A is inhibited by thyroid hor-
mones (Webb et al. 1996; Singleton et al. 1999), and on
the present observation of the important contribution of
20-HETE to the increased tubular sodium excretion in
hypothyroid rats, we expected that CYP4A expression and
20-HETE production would be greater in kidneys from
TX rats than controls. However, the expression of CYP4A
protein and the production of 20-HETE or epoxygenase
metabolites were not different in TX and SHAM rats.
Moreover, the immunohistochemistry indicated that the
intrarenal distribution of CYP4A was similar in TX and
SHAM rats.
Nevertheless, in this study performed on TX rats, ABT
reduced urine flow by 80%, sodium excretion by 81%,
FENa+ by 82%, proximal FENa+ by 28%, and distal
Figure 5. Expression of CYP4A mRNA in renal cortical and
medullary homogenates prepared from SHAM or thyroidectomized
(TX) rats (3–4 animals/group). Total RNA was isolated from tissue
homogenates and CYP4A1, CYP4A2, CYP4A3 and b-actin gene
expressions were determined by RT-PCR.
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FENa+ by 61%. These findings are consistent with the
results of a previous study in normal rats in which
administration of ABT reduced the diuretic and natri-
uretic response to volume expansion by 60–70% (Fernan-
dez et al. 2012). Similarly, our present result show that
inhibition of the synthesis of 20-HETE by HET0016
reduced sodium excretion after volume expansion and
enhanced reabsorption in the distal nephron similar to
ABT. However, the blunting of the response was greater
in ABT than in HET0016-treated rats because ABT but
not HET0016 also enhanced sodium transport in the
proximal tubule. These findings are consistent with the
view that ABT also inhibits the inhibitory effects of EETs
on sodium transport in the proximal tubule.
Neither of these inhibitors modified GFR values in TX
rats suggesting that neither EETs nor 20-HETE contribute
to the decreased GFR in hypothyroid rats. Thus, CYP450
metabolites of arachidonic acid play an important role in
the exaggerated natriuretic response to an acute volume
expansion in hypothyroid rats and this is due largely to
inhibition of sodium transport in the distal nephron.
Indeed fractional delivery of sodium from the distal neph-
ron was four times higher in TX than in SHAM rats after
volume expansion. Inhibition of the formation of
20-HETE with either HET0016 or ABT reduced fractional
delivery of sodium from the distal nephron to the same
level seen in the SHAM control animals. The mechanism
involved remains to be determined. Inhibitors of the for-
mation of 20-HETE have been reported to enhance
sodium transport in the thick ascending loop of Henle
(Zou et al. 1996; Ito and Roman 1999), whereas inhibi-
tion of EETs enhance epithelial sodium channel (ENaC)
activity and sodium transport in the cortical collecting
duct (Pavlov et al. 2011).
It is well known that the increase in endogenously pro-
duced renal DA also contributes to the inhibition of
sodium reabsorption following volume expansion (Hegde
et al. 1989) and we have recently demonstrated that
A B
C D
Figure 6. CYP4A distribution in cortical sections: Positive staining is observed in the cytoplasm of tubular cells (empty arrows) in both SHAM
(Panel A, B) and TX rats (Panel C, D). Staining is more intense in proximal tubule cells (arrowheads) than in thick ascending loop of Henle cells
(empty arrowheads).
Table 3. CYP activity.
ng/0.5 mg protein 60 min
20-HETE Epoxygenaseproducts
SHAM TX SHAM TX
Renal cortex 284  23 214  15 127  13 97  13
Renal medulla 36  4 34  8 89  12 63  18
Values are means  SE. TX thyroidectomized rats. Epoxygenase
activity was calculated as the sum of the products 5,6-EET, 8,9-EET,
11,12-EET, 14,15-EET, and their stable metabolites 5,6- DIHETE,
8,9- DIHETE, 11,12- DIHETE, 14,15- DIHETE, respectively.
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20-HETE plays a critical role in the natriuretic response
to locally synthesized DA (Fernandez et al. 2012). The
fact that in this study DA excretion during volume expan-
sion was lower in TX than in SHAM rats rules out the
possibility that the enhanced natriuretic response to vol-
ume expansion in TX rats was due to the increased intra-
renal formation of DA.
In summary, the results of this study indicate that inhi-
bition of the formation of 20-HETE blunts the enhanced
natriuretic response to volume expansion in thyroidecto-
mized animals by enhancing sodium transport in the distal
nephron. However, TX does not increase the expression of
CYP4A enzymes or the renal production of 20-HETE or
EETs. Since inhibitors of 20-HETE and EETs enhance
sodium transport in TAHL and distal nephron and blunt
the natriuretic response to volume expansion, it is possible
that the effects of the CYP inhibitors reflect a physiological
antagonism of the response to volume expansion in TX
rats, that is, inhibition of the formation of 20-HETE
enhances sodium transport at the tubular level.
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